Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Antithrombotic therapy for stroke in young adults.

Literature DB >> 16205861

Antithrombotic therapy for stroke in young adults.

Abstract

Stroke in young adults is a markedly heterogeneous disease, and remains an understudied phenomenon. While advances are being made in our understanding of the pathophysiology of its underlying conditions, treatment concerns are controversial, and clinical trials are sorely lacking. This review presents an overview of some of the relevant management issues in hypercoagulable states, migraine, patent foramen ovale, vascular dissection and venous sinus thrombosis.

Entities: Disease

Mesh：

Substances：

Year: 2005 PMID： 16205861 DOI： 10.1007/s11239-005-3206-4

Source DB: PubMed Journal: J Thromb Thrombolysis ISSN： 0929-5305 Impact factor: 2.300

82 in total

Review 1. Indications for the closure of patent foramen ovale.

Authors: Michael J Landzberg; Paul Khairy
Journal: Heart Date: 2004-02 Impact factor: 5.994

Review 2. Neurology and the blood: haematological abnormalities in ischaemic stroke.

Authors: H S Markus; H Hambley
Journal: J Neurol Neurosurg Psychiatry Date: 1998-02 Impact factor: 10.154

3. Infarcts of undetermined cause: the NINCDS Stroke Data Bank.

Authors: R L Sacco; J H Ellenberg; J P Mohr; T K Tatemichi; D B Hier; T R Price; P A Wolf
Journal: Ann Neurol Date: 1989-04 Impact factor: 10.422

4. Recurrent cerebrovascular events associated with patent foramen ovale, atrial septal aneurysm, or both.

Authors: J L Mas; C Arquizan; C Lamy; M Zuber; L Cabanes; G Derumeaux; J Coste
Journal: N Engl J Med Date: 2001-12-13 Impact factor: 91.245

5. Heparin treatment in sinus venous thrombosis.

Authors: K M Einhäupl; A Villringer; W Meister; S Mehraein; C Garner; M Pellkofer; R L Haberl; H W Pfister; P Schmiedek
Journal: Lancet Date: 1991-09-07 Impact factor: 79.321

Review 6. Genetics and ischaemic stroke.

Authors: A Hassan; H S Markus
Journal: Brain Date: 2000-09 Impact factor: 13.501

Review 7. Stroke treatment-specific considerations.

Authors: S E Kasner
Journal: Neurol Clin Date: 2000-05 Impact factor: 3.806

8. Natural history and risk factors for thrombosis in 360 patients with antiphospholipid antibodies: a four-year prospective study from the Italian Registry.

Authors: G Finazzi; V Brancaccio; M Moia; N Ciaverella; M G Mazzucconi; P C Schinco; M Ruggeri; E M Pogliani; G Gamba; E Rossi; F Baudo; C Manotti; A D'Angelo; G Palareti; V De Stefano; M Berrettini; T Barbui
Journal: Am J Med Date: 1996-05 Impact factor: 4.965

9. Factor V Leiden mutation in cerebral venous thrombosis.

Authors: M Zuber; P Toulon; L Marnet; J L Mas
Journal: Stroke Date: 1996-10 Impact factor: 7.914

Review 10. Management of thrombophilia.

Authors: K A Bauer
Journal: J Thromb Haemost Date: 2003-07 Impact factor: 5.824

2 in total

Review 1. Inherited and acquired risk factors for arterial ischemic stroke in childhood.

Authors: Giuseppe Lippi; Massimo Franchini; Martina Montagnana; Gian Luca Salvagno; Giovanni Targher; Gian Cesare Guidi
Journal: J Thromb Thrombolysis Date: 2008-02-10 Impact factor: 2.300

2. Role of investigating thrombophilic disorders in young stroke.

Authors: Kay W P Ng; Pei K Loh; Vijay K Sharma
Journal: Stroke Res Treat Date: 2011-02-08

2 in total